These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 3774652)

  • 1. The association of aplasia cutis congenita with therapy of maternal thyroid disease.
    Kalb RE; Grossman ME
    Pediatr Dermatol; 1986 Sep; 3(4):327-30. PubMed ID: 3774652
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aplasia cutis congenita and methimazole.
    Bachrach LK; Burrow GN
    Can Med Assoc J; 1984 May; 130(10):1264. PubMed ID: 6722686
    [No Abstract]   [Full Text] [Related]  

  • 3. Aplasia cutis congenita and other anomalies associated with methimazole exposure during pregnancy.
    Rodríguez-García C; González-Hernández S; Hernández-Martín A; Pérez-Robayna N; Sánchez R; Torrelo A
    Pediatr Dermatol; 2011; 28(6):743-745. PubMed ID: 21995270
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of graves' disease with antithyroid drugs in the first trimester of pregnancy and the prevalence of congenital malformation.
    Yoshihara A; Noh J; Yamaguchi T; Ohye H; Sato S; Sekiya K; Kosuga Y; Suzuki M; Matsumoto M; Kunii Y; Watanabe N; Mukasa K; Ito K; Ito K
    J Clin Endocrinol Metab; 2012 Jul; 97(7):2396-403. PubMed ID: 22547422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Aplasia cutis as a teratogenic effect of methimazole].
    Díez-Delgado Rubio J; Belmonte Martín MJ; Calvo Bonachera MD; López Candel E
    An Esp Pediatr; 1999 Sep; 51(3):290-2. PubMed ID: 10575754
    [No Abstract]   [Full Text] [Related]  

  • 6. Treatment of hyperthyroidism in pregnancy with propylthiouracil and methimazole.
    Mujtaba Q; Burrow GN
    Obstet Gynecol; 1975 Sep; 46(3):282-6. PubMed ID: 51489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Review of antithyroid drug use during pregnancy and report of a case of aplasia cutis.
    Mandel SJ; Brent GA; Larsen PR
    Thyroid; 1994; 4(1):129-33. PubMed ID: 7519913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Antithyroid agents and embryopathies].
    Bournaud C; Orgiazzi J
    Ann Endocrinol (Paris); 2003 Nov; 64(5 Pt 1):366-9. PubMed ID: 15067747
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aplasia cutis congenita in surviving co-twin after propylthiouracil exposure in utero.
    Löllgen RM; Calza AM; Schwitzgebel VM; Pfister RE
    J Pediatr Endocrinol Metab; 2011; 24(3-4):215-8. PubMed ID: 21648296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Aplasia cutis after exposure to carbimazole in utero].
    Dutertre JP; Jonville AP; Moraine C; Autret E
    J Gynecol Obstet Biol Reprod (Paris); 1991; 20(4):575-6. PubMed ID: 1885895
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aplasia cutis congenita due to methimazol exposure within the first trimester of pregnancy: case report.
    Akar M; Dilli D; Sandal G; Erdeve Ö; Dilmen U
    J Perinat Med; 2011 Nov; 39(6):743-4. PubMed ID: 21809898
    [No Abstract]   [Full Text] [Related]  

  • 12. Drug therapy for Graves' disease during pregnancy.
    N Engl J Med; 1986 Dec; 315(23):1485-6. PubMed ID: 3785300
    [No Abstract]   [Full Text] [Related]  

  • 13. Propylthiouracil versus methimazole in treatment of Graves' disease during pregnancy.
    Chattaway JM; Klepser TB
    Ann Pharmacother; 2007 Jun; 41(6):1018-22. PubMed ID: 17504839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aplasia cutis congenita of the scalp in an infant exposed to valproic acid in utero.
    Hubert A; Bonneau D; Couet D; Berthier M; Oriot D; Larrègue M
    Acta Paediatr; 1994 Jul; 83(7):789-90. PubMed ID: 7949818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pregnancy outcome in women treated with methimazole or propylthiouracil during pregnancy.
    Gianetti E; Russo L; Orlandi F; Chiovato L; Giusti M; Benvenga S; Moleti M; Vermiglio F; Macchia PE; Vitale M; Regalbuto C; Centanni M; Martino E; Vitti P; Tonacchera M
    J Endocrinol Invest; 2015 Sep; 38(9):977-85. PubMed ID: 25840794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aplasia cutis congenita following in utero methimazole exposure.
    Baid SK; Merke DP
    J Pediatr Endocrinol Metab; 2007 May; 20(5):585-6. PubMed ID: 17642418
    [No Abstract]   [Full Text] [Related]  

  • 17. Ectodermal abnormalities associated with methimazole intrauterine exposure.
    Martin-Denavit T; Edery P; Plauchu H; Attia-Sobol J; Raudrant D; Aurand JM; Thomas L
    Am J Med Genet; 2000 Oct; 94(4):338-40. PubMed ID: 11038449
    [No Abstract]   [Full Text] [Related]  

  • 18. Which anti-thyroid drug?
    Cooper DS
    Am J Med; 1986 Jun; 80(6):1165-8. PubMed ID: 3755286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The safety of methimazole and propylthiouracil in pregnancy: a systematic review.
    Hackmon R; Blichowski M; Koren G
    J Obstet Gynaecol Can; 2012 Nov; 34(11):1077-1086. PubMed ID: 23231846
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thyrotoxicosis in pregnancy.
    Emerson CH
    Curr Ther Endocrinol Metab; 1994; 5():275-7. PubMed ID: 7704731
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.